A targeted agent to mitigate sepsis

Researchers have developed a targeted therapy (ABTAA) for mitigating sepsis by strengthening as well as protecting blood vessels. ABTAA is a separate, independent treatment which eliminates the root cause of sepsis so the body has a strong battlefield to fight the infection.